Iseulys Richert

Iseulys Richert is an R&D Scientist at Brenus Pharma, specializing in the development of First-In-Class tumor antigen-focused immunotherapies since September 2024. Previously, as Principal Scientist in immuno-oncology at DOMAIN Therapeutics, Iseulys contributed to the creation of immuno-oncology platforms and led non-clinical development projects targeting GPCR. Early career experience includes roles as a Junior Research Officer and Laboratory Assistant at Centre Léon Bérard, focusing on bone sarcomas and immunotherapy research. Additionally, Iseulys has extensive experience in pharmacy, with positions at various hospitals and community pharmacies, gaining skills in patient interaction and pharmaceutical care. Education encompasses a Doctor of Pharmacy from the Faculty of Pharmacy in Strasbourg, a Master's in Drug Design and Production, and a Master's in Therapeutic Innovation in Oncology.